Skip to main content
. 2021 Jun 1;13(11):2741. doi: 10.3390/cancers13112741

Table 3.

Second joint utility function, U2(m, QOL), of mean survival time (m, in months) and quality of life (QOL) combinations for patients with metastatic clear cell renal cell carcinoma, defined by U2(m, good QOL) = 10 · m0.2/0.2 and U2(m, poor QOL) = 9.5 · m0.3/0.3, given that U2(0, good or poor QOL) = 0.

Mean Survival Time (Months)
QOL 1 2 3 4 12 18 24 30 36
Good 50 57 62 66 82 89 94 99 103
Poor 32 39 44 48 67 75 82 88 93